Your session is about to expire
← Back to Search
Jaspr Health App for Suicidal Thoughts
N/A
Waitlist Available
Led By Linda A. Dimeff, PhD
Research Sponsored by Evidence-Based Practice Institute, Seattle, WA
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18+ years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (time 1), 4 weeks (time 2), 8 weeks (time 3), 12 weeks (time 4)
Awards & highlights
Study Summary
This trial is testing a new expanded Jaspr2.0 to efficiently and reliably aid delivery of recommended best-practices for the treatment of suicidal ideation in adults, including suicidal individuals who also misuse alcohol.
Who is the study for?
Adults over 18 with suicidal thoughts, who have seen their primary care provider in the past year, use a smartphone with data, and may misuse alcohol can join. Those with severe depression or alcohol dependence, acute suicidal tendencies, or significant drug abuse cannot participate.Check my eligibility
What is being tested?
The trial is testing Jaspr2.0 app against an active control (Virtual Hope Box + wellness resources) for helping adults manage suicidal ideation and alcohol misuse. It's a randomized study assessing participants at multiple points over 12 weeks.See study design
What are the potential side effects?
Since this trial involves digital interventions rather than medications, traditional side effects are not expected; however, users might experience emotional discomfort or distress from the content.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (time 1), 4 weeks (time 2), 8 weeks (time 3), 12 weeks (time 4)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (time 1), 4 weeks (time 2), 8 weeks (time 3), 12 weeks (time 4)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Alcohol Use Disorders Identification Test
Change in Patient Health Questionnaire-9
Change in Suicidal Behaviors Questionnaire-Revised
+1 moreSecondary outcome measures
App Satisfaction Survey
Change in Suicide Attempt Self-Injury Interview
Other outcome measures
Ask Suicide Screening Questions
Columbia-Suicide Severity Rating Scale
Demographics Questionnaire
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Jaspr2.0Experimental Treatment1 Intervention
Suicide prevention platform that includes evidence-based practices for suicide prevention and alcohol misuse for use in primary care. Jaspr2.0 includes psychoeducation, behavioral skills training, crisis stabilization planning, lethal means management, brief interventions for the treatment of alcohol misuse, and messages of hope, wisdom, and insights from people with lived experience (PLE). Participants in this condition will also have access to the Jaspr2.0 companion mobile app, Jaspr-at-Home.
Group II: Active-Control app + electronic wellness resources brochureActive Control1 Intervention
Well-regarded suicide prevention self-help app, plus an electronic wellness resources brochure containing links to health and wellness materials, psychoeducation about suicide, depression, self-help recovery-focused resources (e.g., Alcoholics Anonymous, other 12-Step programs, Moderation Management, etc.), and phone/text information for the National Suicide Prevention Lifeline.
Find a Location
Who is running the clinical trial?
Evidence-Based Practice Institute, Seattle, WALead Sponsor
8 Previous Clinical Trials
29,657 Total Patients Enrolled
6 Trials studying Suicide
29,343 Patients Enrolled for Suicide
Linda A. Dimeff, PhDPrincipal InvestigatorChief Scientific Officer
1 Previous Clinical Trials
88 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.You are currently feeling very suicidal or have had recent thoughts of hurting yourself.I have severe depression based on my PHQ-9 score.
Research Study Groups:
This trial has the following groups:- Group 1: Jaspr2.0
- Group 2: Active-Control app + electronic wellness resources brochure
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor accepting new participants?
"A review of clinicaltrials.gov suggests that this medical study is not currently recruiting participants. The trial was published on May 15th 2023 and last updated on June 17th 2022, however there are hundreds of other studies actively enrolling patients at present time."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger